Financials

  • Market Capitalization 386.27 M
  • Employee 345
  • Founded N/A
  • CEO N/A
  • Website www.cerus.com
  • Headquarter Delaware, United States
  • FIGI BBG000HBVZX8
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-25.75
売上高対価格比率
1.68

Cerus Corporation

Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry.

ニュース